JT
INO icon

Jupiter Topco’s Inovio Pharmaceuticals INO Stock Holding History

Jupiter Topco’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.71M Buy
+5,171,053
New +$6.14M ﹤0.01% 994

Other funds holding INO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CM
Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return

Jupiter Topco's INO Position: Q2 2026 in Review

Jupiter Topco opened a new position in Inovio Pharmaceuticals (INO) in Q2 2026: 5,171,053 shares worth $5.71M. The stake represents ﹤0.01% of the portfolio and ranks #994 among its holdings.

102 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • Jupiter Topco held 5,171,053 shares of Inovio Pharmaceuticals worth $5.71M as of Q2 2026.
  • Inovio Pharmaceuticals was a new Jupiter Topco position in Q2 2026.
  • Inovio Pharmaceuticals made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #994 holding.
  • 102 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.